Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ars Arthro Biyoteknoloji is a Turkish biotechnology company specializing in the development and manufacture of advanced orthopedic and dermatological solutions. The company focuses on viscosupplementation therapies, particularly hyaluronic acid-based injections for the treatment of osteoarthritis and joint-related conditions. Their product portfolio includes high-molecular-weight sodium hyaluronate formulations designed to restore joint lubrication and alleviate pain. Beyond orthopedics, Ars Arthro develops products for wound management and aesthetic dermatology. The company operates out of the Hacettepe University Technopolis, leveraging academic research to produce CE-certified medical devices for international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ars Arthro Biyoteknoloji.